姜黄素抑制TGF-β1诱导的人肾小管上皮细胞系表型转化

基础医学与临床 ›› 2020, Vol. 40 ›› Issue (1): 48-53.

姜黄素抑制TGF-β1诱导的人肾小管上皮细胞系表型转化

陈民佳¹, 杜娟¹, 袁丹凤¹, 张蜀¹, 黄宏¹, 朱方强^2*

1.陆军军医大学大坪医院创伤、烧伤与复合伤国家重点实验室,重庆 400042;
2.重庆医科大学第三附属医院泌尿外科,重庆 401120

收稿日期:2019-06-06 修回日期:2019-11-12 出版日期:2020-01-05 发布日期:2019-12-27
通讯作者: ^*zfq68757079@sina.com
基金资助:
国家自然科学基金(81571912,81372059);重庆市院士牵头科技创新引导专项(cstc2017zdcy-yszxX0002);创伤、烧伤与复合伤国家重点实验室开放基金(200717);重庆高校创新团队建设计划资助项目(CXTDX201601005)

Curcumin inhibits TGF-β1-induced phenotypic transition of human kidney tubular cells (HKCs)

CHEN Min-jia¹, DU Juan¹, YUAN Dan-feng¹, ZHANG Shu¹, HUANG Hong¹, ZHU Fang-qiang^2*

1. State Key Laboratory of Trauma, Burn and Combined Injury, Daping Hospital, Army Medical University, Chongqing 400042;
2. Department of Urology, the Third Affiliated Hospital of Chongqing Medical University, Chongqing 401120, China

Received:2019-06-06 Revised:2019-11-12 Online:2020-01-05 Published:2019-12-27
Contact: ^*zfq68757079@sina.com

摘要/Abstract

摘要： 目的探讨姜黄素抑制TGF-β1诱导的肾纤维化的作用及分子生物学机制。方法应用10 ng/mL TGF-β1单独或联合姜黄素(Cur)(6.25、12.5、25、50和100 μmol/L)共同作用人肾小管上皮细胞系(HKCs)72 h,倒置相差显微镜下观察细胞形态,免疫组化检测纤维细胞特异蛋白-1 (FSP-1)表达;同时,通过Western blot检测肾小管上皮细胞标志物E-cardhrin和细胞角化蛋白以及基质标志物波形蛋白、α-平滑肌肌动蛋白(α-SMA)和Ⅰ型胶原的表达变化,以及AKT/mTOR信号通路关键蛋白的表达。结果 HKCs贴壁增殖,呈铺路石样外观。TGF-β1单独刺激能明显促进细胞由上皮样形态向纤维样细胞形态转化。当TGF-β1与姜黄素联合作用于HKCs时,姜黄素在12.5～50 μmol/L浓度时能明显对抗TGF-β1诱导的细胞形态转变而维持HKCs细胞铺路石样外观,同时,TGF-β1能明显抑制HKCs细胞E-cardhrin和角化蛋白基因表达(P＜0.05,P＜0.01),而促进FSP1阳性细胞显著增加(P＜0.05,P＜0.01);上调波形蛋白、α-SMA和I型胶原的表达(P＜0.05,P＜0.01);并且,AKT/mTOR信号通路关键蛋白Akt、mTOR、p70S6K、4E-BP1和eIF4E的磷酸化水平表达也显著增加(P＜0.05,P＜0.01)。而姜黄素能抑制TGF-β1诱导的HKCs表型转化,同时下调TGF-β1诱导AKT/mTOR信号通路关键蛋白的磷酸化水平(P＜0.05)。结论姜黄素通过抑制Akt/mTOR信号通路对抗TGF-β1诱导的上皮细胞-间质细胞转化,可能是姜黄素抗肾纤维化的关键分子机制之一。

关键词: 姜黄素, 肾纤维化, 上皮-间质细胞转化, TGF-β1, Akt/mTOR信号通路

Abstract: Objective To study the effects of curcumine on renal tubular epithelial-mesenchymal transition (EMT) and its possible mechanisms. Methods The effect of curcumin on the morphology of human kidney cells (HKCs) in the presence of TGF-β1 alone or in combination with different concentration curcumine was observed by phase contrast microscopy. The expressions of E-cardhrin, keratin, vimentin, alpha smooth muscle actin (α-SMA),fibroblast-specific protein 1 (FSP1) and key proteins of AKT/mTOR pathway were analyzed by immunohistochemical stain and Western blot. Results HKC cells showed a classic cobblestone morphology. Exposure of HKCs to TGF-β1 for 72 h induced a complete conversion of the epithelial cell to myofibroblast. When HKCs were co-incubated with TGF-β1 and various concentrations of curcumin for 72 h, curcumine maintained the epithelial morphology in a dose-dependent manner (from 12.5 to 50 μg/mL), antagonizing TGF-β1-induced the down-regulation expression of E-cardhrin, keratin and the up-rgulation of FSP1, vimentin and α-SMA. Importantly. Curcumine effectively suppressed the activity of the Akt/mTOR pathway in HKCs as demonstrated by a remarkable reduction of the Akt, mTOR, p70S6K, 4E-BP1和eIF4E phosphorylation. Conclusions Curcumine is a potent inhibitor of TGF-β1-induced epithelial-mesenchymal transition (EMT) and antagonizes TGF-β1-driven fibrogenesis through inhibition of the activity of the Akt/mTOR pathway.

Key words: curcumine, renal fibrosis, epithelialto-mesenchymal transition (EMT), TGF-β1, AKt/mTOR pathway

中图分类号:

R363.2

陈民佳, 杜娟, 袁丹凤, 张蜀, 黄宏, 朱方强. 姜黄素抑制TGF-β1诱导的人肾小管上皮细胞系表型转化[J]. 基础医学与临床, 2020, 40(1): 48-53.

CHEN Min-jia, DU Juan, YUAN Dan-feng, ZHANG Shu, HUANG Hong, ZHU Fang-qiang. Curcumin inhibits TGF-β1-induced phenotypic transition of human kidney tubular cells (HKCs)[J]. Basic & Clinical Medicine, 2020, 40(1): 48-53.

参考文献

[1]Cruz-Solbes AS, Youker K. Epithelial to mesenchymal transition (EMT) and endothelial to mesenchymal transition (EndMT): Role and implications in Kidney fibrosis [J]. Results Probl Cell Differ, 2017, 60: 345-372.
[2]Zeisberg M, Kalluri R. The role of epithelial-to-mesenchymal transition in renal fibrosis [J]. J Mol Med, 2004, 82: 175-181.
[3]Syed F, Sherris D, Paus R, et al. Keloid disease can be inhibited by antagonizing excessive mTOR signaling with a novel dual TORC1/2 inhibitor[J]. Am J Pathol, 2012, 184: 1253-1261.
[4]Fantus D, Rogers NM, Grahammer F, et al. Roles of mTOR complexes in the kidney: implications for renal disease and transplantation[J]. Nat Rev Nephrol, 2016, 12: 587-609.
[5]Sun X, Liu Y, Li C, et al. Recent advances of curcumin in the prevention and treatment of renal fibrosis[J]. Biomed Res Int, 2017, 2017: 2418671.doi:10.1155/2017/2418671.
[6]Saidi A, Kasabova M, Vanderlynden L, et al. Curcumin inhibits the TGF-β1-dependent differentiation of lung fibroblasts via PPARγ-driven upregulation of cathepsins B and L[J]. Sci Rep, 2019, 9:491.doi:10.1038/s41598-018-36858-3.
[7]Gsedeke J, Noble NA, Border WA. Curcumin blocks multiple sites of the TGF-b signaling cascade in renal cells[J]. Kidney Int, 2004, 66: 112-120.
[8]Zeisberg M, Duffield JS. Resolved: EMT produces fibroblasts in the kidney[J]. J Am Soc Nephrol, 2010, 21: 1247-1253.
[9]Zeisberg M, Hanai J, Sugimoto H, et al. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transi-tion and reverses chronic renal injury[J]. Nat Med, 2003, 9: 964-968.
[10]Kuwabara N, Tamada S, Iwai T, et al. Attenuation of renal fibrosis by curcumin in rat obstructive nephropathy[J]. Urology, 2006, 67: 440-446.
[11]Loeffler I, Wolf G. Transforming growth factor-beta and the proression of renal disease[J]. Nephrol Dial Transplant,2014, 29:i37-i45.
[12]Tan RJ, Zhou D, Zhou L, et al. Wnt/β-catenin signaling and kidney fibrosis[J]. Kidney Int, 2014, 4: 84-90.
[13]Copeland JW, Beaumont BW, Merrilees MJ, et al. Epithelial-to-mesenchymal transition of human proximal tubular epithelial cells: effects of rapamycin, mycophenolate, cyclosporin, azathioprine, and methylprednisolone[J]. Transplantation, 2007, 83:809-814.

[1]	田亚婷, 张芳, 张博翔, 李甜. 马里苷减轻糖尿病小鼠心肌纤维化[J]. 基础医学与临床, 2024, 44(1): 51-56.
[2]	鲁益朦, 谭季春. 宫腔粘连发病的分子机制研究进展[J]. 基础医学与临床, 2023, 43(4): 547-553.
[3]	黄驿胜, 叶启文, 王竞枫. miR-203a-3p抑制人肝癌细胞系增殖[J]. 基础医学与临床, 2023, 43(1): 87-94.
[4]	贾春松, 赵彦坡, 尚振华, 邢添瑛, 欧彤文. RNA干扰降低膀胱TGF-β1表达能够改善脊髓损伤大鼠的膀胱功能和纤维化[J]. 基础医学与临床, 2021, 41(7): 1007-1012.
[5]	程继, 付国, 赵华才, 王志刚, 高丹, 董青川. 姜黄素提高人前列腺癌细胞系PC-3放疗敏感性[J]. 基础医学与临床, 2021, 41(12): 1792-1796.
[6]	吴娜, 王东, 李京敏, 白咸勇. 羟基红花黄色素A抑制人肝癌细胞系Huh7发生上皮-间质转化[J]. 基础医学与临床, 2021, 41(10): 1423-1427.
[7]	李招兵, 马小峰, 江振涛, 黄云辉. 烟酸姜黄素酯抑制LPS诱导的HUVECs分泌炎性细胞因子与内质网应激[J]. 基础医学与临床, 2021, 41(1): 62-67.
[8]	刘盼盼, 张子锐, 杨旭, 韩晶, 陆连芳, 王爱敏, 张菊. 姜黄素减轻小鼠深部组织压力性损伤[J]. 基础医学与临床, 2020, 40(3): 299-304.
[9]	卢守燕马志刚黄军悦李莹屏黄文辉. 氯沙坦钾下调尿酸性肾纤维化大鼠肾小管上皮细胞尿酸转运蛋白-1的表达[J]. 基础医学与临床, 2019, 39(5): 720-725.
[10]	程邵龙赵亮肖明朝. 姜黄素降低III型CP/CPPS模型鼠炎性反应因子的表达[J]. 基础医学与临床, 2017, 37(4): 525-530.
[11]	程再轩刘红岗董小平张勇同李平朱以芳. BMP-7不能逆转TGF-β1诱导的人支气管上皮细胞上皮间质转换[J]. 基础医学与临床, 2017, 37(12): 1750-1752.
[12]	段争吴翠红. 细颗粒物（PM2.5）暴露加重博来霉素致大鼠肺纤维化[J]. 基础医学与临床, 2015, 35(6): 781-785.
[13]	王柏琦陈艳华蒋丽琴程爱兰. 姜黄素对鼻咽癌细胞系CNE-1 RECK基因表达及甲基化的影响[J]. 基础医学与临床, 2014, 34(6): 729-733.
[14]	赵金红王伟张新金李建美. 促红细胞生成素抑制AngⅡ诱导的大鼠心肌细胞肥大及其可能的信号通路[J]. 基础医学与临床, 2014, 34(3): 295-300.
[15]	葛正行周洵高瑞李波. rHSG对COPD大鼠小气道阻力及成纤维细胞TGF-β1表达的影响[J]. 基础医学与临床, 2014, 34(11): 1482-1485.